FLUSH MAXIMUM STRENGTH ANTIFUNGAL FORMULA- undecylenic acid liquid 
Triple Point Group, LLC

----------

CRYSTAL FLUSH Maximum Strength Antifungal formula

DRUG FACTS:

Active Ingredient

Undecylenic Acid 25%

Purpose

Anti-fungal

Uses:

For cure of most: • ringworm (tinea corporis) • athlete's foot (tinea pedis). For the relief of: • itching• scaling • cracking • burning • redness • soreness • irritation and discomforts which may accompany these conditions. 

Warnings:

For external use only.

Ask a doctor before use

on children under two years of age

DO NOT USE

on diaper rash. 

When using this product

avoid contact with eyes.

Stop use and ask a doctor if

  • irritation occurs
  • there is no improvement within four weeks.

KEEP OUT OF REACH OF CHILDREN.

If swallowed, get medical help or contact a Poison Control Center right away. 

If pregnant or breast-feeding, 

ask a health professional before use.

Directions:

Other ingredients:

Cymbopogan Nardus (Citronella) Oil, Lavandula Angustifolia (Lavender) Oil, Melaleuca Alternifolia (Tea Tree) Oil, Prunus Amygdalus Dulcis (Sweet Almond) Oil, Simmondsia Chinensis (Jojoba) Oil, Syzygium Aromaticum (Clovebud) Oil, Tocopheryl Acetate (Vitamin E).

Package Labeling

Bottle

FLUSH MAXIMUM STRENGTH ANTIFUNGAL FORMULA 
undecylenic acid liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:80569-084
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
UNDECYLENIC ACID (UNII: K3D86KJ24N) (UNDECYLENIC ACID - UNII:K3D86KJ24N) UNDECYLENIC ACID250 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CITRONELLA OIL (UNII: QYO8Q067D0)  
LAVENDER OIL (UNII: ZBP1YXW0H8)  
TEA TREE OIL (UNII: VIF565UC2G)  
ALMOND OIL (UNII: 66YXD4DKO9)  
JOJOBA OIL (UNII: 724GKU717M)  
CLOVE OIL (UNII: 578389D6D0)  
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:80569-084-1515 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product09/17/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00509/17/2020
Labeler - Triple Point Group, LLC (058482713)

Revised: 11/2023
Document Id: 09e240de-0009-c20f-e063-6294a90a09c4
Set id: 1d9e56ef-c7c9-4aff-ab9e-b163e566e3d5
Version: 6
Effective Time: 20231111
 
Triple Point Group, LLC